16650-63-8

Basic information

• Product Name: 3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER
• Synonyms: METHYL 3-BROMONAPHTHALENE-1-CARBOXYLATE;3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER;3-BroMo-naphtalene-1-carboxylic acid Methyl ester
• CAS NO: 16650-63-8
• Molecular Formula: C₁₂H₉BrO₂
• Molecular Weight: 265.1
• Mol File: 16650-63-8.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 353.9±15.0 °C(Predicted)
• Appearance: /
• Density: 1.492±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER(16650-63-8)
• EPA Substance Registry System: 3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER(16650-63-8)

Safety Data

• Hazardous Substances Data: 16650-63-8(Hazardous Substances Data)

Usage

General Description

3-Bromo-naphthalene-1-carboxylic acid methyl ester is a chemical compound that belongs to the family of naphthalene derivatives. It is a methyl ester of 3-bromo-1-naphthoic acid with a carboxylic acid group and a bromine atom attached to the naphthalene ring. 3-BROMO-NAPHTHALENE-1-CARBOXYLIC ACID METHYL ESTER has various applications in the field of organic synthesis and pharmaceutical research, where it is used as a building block for the synthesis of new compounds and as a reagent in chemical reactions. It has the potential to exhibit biological activity and is of interest in the development of new drugs and pharmaceutical products. Additionally, it is used in the manufacturing of dyes, pigments, and other industrial chemicals. Overall, 3-bromo-naphthalene-1-carboxylic acid methyl ester is an important chemical compound with diverse applications in research, development, and industry.

Upstream product

• 81-84-5 1,8-Naphthalic anhydride 
• 54978-07-3 3-nitro-1-naphthalenecarboxylic acid chloride 
• 4507-84-0 3-nitro-1-naphthoic acid 
• 67-56-1 methanol 
• 16726-66-2 3-bromo-1-naphthoic acid 
• 24050-49-5 3-bromonaphthalic-1,8-anhydride 
• 88790-90-3 methyl 3-amino-5,6,7,8-tetrahydro-1-naphthoate 
• 186581-53-3 diazomethane 

Downstream Products

• 79996-92-2 (3-bromonaphthalen-1-yl)methanol 
• 1033204-03-3 3-(4-cyano-phenyl)-naphthalene-1-carboxylic acid methyl ester 
• 1033204-02-2 3-(4-methoxy-phenyl)-naphthalene-1-carboxylic acid methyl ester 
• 1033204-01-1 3-phenyl-naphthalene-1-carboxylic acid methyl ester 
• 1354965-48-2 methyl 3-(4-phenyl-1H-1,2,3-triazol-1-yl)-1-naphthoate 
• 1354965-50-6 3-(4-phenyl-1H-1,2,3-triazol-1-yl)-1-naphthoic acid 
• 954410-14-1 C₃₈H₃₈FN₅O₅ 
• 954410-12-9 methyl 3-((3S)-3-(azidomethyl)-4-{[1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H-imidazol-4-yl]carbonyl}piperazin-1-yl)-1-naphthoate 
• 954410-06-1 [(2S)-1-{[1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-4-(4-{[(triisopropylsilyl)oxy]methyl}-2-naphthyl)piperazin-2-yl]methyl acetate 
• 1244017-19-3 methyl 3-(phenylethynyl)-1-naphthoate 

Relevant articles and documents

COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION

Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.

Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators

Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.

SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS

Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.